Superworth

Treace Medical Concepts price to sales ratio TMCI

Market value divided by revenue over the last twelve months, since 2022.

Today, Oct 23, 2026
1.4×
5-year median
2.6×
Against its 5-year history
17th
percentile: 0 is its lowest day, 100 its highest
5-year range
0.4× to 12.0×
Peer median
1.8×

Treace Medical Concepts' price to sales ratio is 1.4× as of Oct 23, 2026.

That is below its 5-year median of 2.6×, lower than on 83% of days in the last 5 years.

Over that time it ranged from 0.4× in Mar 2026 to 12.0× in Apr 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 1.8×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.4×0.4×1.5×
20250.7×0.7×3.1×
20242.1×1.4×5.5×
20234.5×2.2×12.0×
202210.2×7.7×11.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Treace Medical Concepts' size, closest first, today.

CompanyPrice to sales ratio
TMCITreace Medical Concepts1.4×
INFUInfuSystem1.9×
UTMDUtah Medical Products6.5×
EMBCEmbecta0.4×
PDEXPro DEX2.6×
TCMDTactile Systems Technology1.5×
MDXGMimedx1.6×
MOVMovado1.0×
KEQUKewaunee Scientific0.3×
IRMDIradimed12.7×
STAAStaar Surgical3.3×
Peer median1.8×

Where Treace Medical Concepts ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Treace Medical Concepts

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.